Cycling sits in its own corner of the sports-recovery conversation. Unlike running, golf or CrossFit, the dominant damage is not impact - it's postural, chronic, and metabolic. A serious cyclist isn't recovering from a single hard event; they're recovering from a season of accumulated training-stress score, miles in the drops, and weeks of nutritional load that never quite catches up. That's a different research literature, and a different set of compounds the conversation keeps returning to.
RUO framing throughout. New-U supplies all compounds named below strictly as laboratory reagents. UCI and USA Cycling enforce WADA's S2 prohibited list rigorously - this is one of the most thoroughly tested sports in the world.
Sports-medicine literature on cyclists consistently identifies five chronic-overuse patterns:
| Structure | What loads it | Typical chronic pattern |
|---|---|---|
| IT band / lateral knee | Repeated knee flexion, cleat alignment, saddle height issues | Iliotibial band friction syndrome, lateral knee pain |
| Patellofemoral joint | Sustained mid-range knee load on the pedal stroke | Patellofemoral pain syndrome (“runner's knee” in cyclists) |
| Lumbar spine | Sustained flexion in the drops, hours per session | Lumbar disc compression, paraspinal hypertonicity |
| Cervical / trapezius | Looking up from drop-bar position | Trapezius trigger points, cervical compression, neck pain |
| Metabolic system | Sustained training-stress score above recovery capacity | Overreaching, mitochondrial stress, hormonal dysregulation |
That last row matters more than the other four for serious endurance athletes. Cyclists don't usually break tendons - they accumulate cumulative metabolic damage. The research literature on mitochondrial-supportive peptides lands directly there.
| Compound | Mechanism | Cycling-relevant fit |
|---|---|---|
| MOTS-c | Mitochondrial-derived peptide; biogenesis, insulin sensitivity, exercise capacity | The endurance compound - mitochondrial efficiency is the rate-limiter for sustained aerobic output |
| BPC-157 | Angiogenesis, fibroblast migration, gut-lining repair | IT band, patellar tendon; also the gut-lining stress from sustained high-carb fueling |
| TB-500 | Cell migration, broader tissue mobilisation | Cervical / trapezius soft-tissue recovery; the “Wolverine stack” partner |
| CJC-1295 + Ipamorelin | GH-axis pulsatile release; deep-sleep architecture | Sleep is where endurance athletes adapt; volume crushes sleep quality |
| Epitalon | Pineal-gland modulation; circadian / sleep research literature | Endurance training disrupts circadian rhythm; the research interest is sleep / recovery cadence |
UCI / WADA warning. Cycling is among the most thoroughly drug-tested sports in the world. Every compound above is banned in sanctioned competition: MOTS-c, TB-500, CJC-1295, Ipamorelin under WADA S2; BPC-157 captured by catch-all clauses; even GLP-1 receptor agonists falling under prescription-control restrictions. UK, US, Belgian, Italian and French national federations all enforce WADA rules at amateur level. Don't use these in competition.
What makes the cycling peptide conversation different from CrossFit or bodybuilding is the central biology being targeted. Strength-sport recovery is about connective tissue. Endurance recovery is about mitochondria, hormones, and sleep architecture. The compounds that matter shift accordingly:
The connective-tissue compounds - BPC-157, TB-500 - still matter for the IT band, lumbar and cervical patterns, but for endurance athletes they're secondary to the mitochondrial-peptide (MOTS-c) case, not primary.
Sealed vials of MOTS-c, BPC-157, TB-500 and the wider research catalog, >99% purity by Janoshik / Freedom Diagnostics. Research use only - not for human consumption. Banned in UCI / WADA-tested competition.
Browse the catalog